Lazard Asset Management’s Twist Bioscience TWST Stock Holding History
Bought
Maintained
Sold
Other funds holding TWST
Lazard Asset Management's TWST Position: Q3 2026 in Review
Lazard Asset Management reduced its Twist Bioscience (TWST) stake by 30% in Q3 2026, selling an estimated $1.32M and leaving 25,098 shares worth $4.85M. The position accounts for 0.01% of the portfolio, ranked #624.
Lazard Asset Management first reported a position in TWST in Q4 2019 and has held it in 22 quarters since. 433 funds tracked by Wall St. Rank hold TWST as of Q3 2026.
- Lazard Asset Management held 25,098 shares of Twist Bioscience worth $4.85M as of Q3 2026.
- Lazard Asset Management sold 10,652 Twist Bioscience shares in Q3 2026, an estimated $1.32M.
- Twist Bioscience made up 0.01% of Lazard Asset Management's portfolio in Q3 2026, its #624 holding.
- Lazard Asset Management first reported a position in Twist Bioscience in Q4 2019 and has held it in 22 quarters since.
- 433 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2026.
Based on Lazard Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.